Many longevity clinics began offering BPC-157 and GHK-Cu injections after the FDA eased its peptide restrictions in April 2026. Neither peptide is cleared for compounded injection, and the published human data on both is thin. Most cosmetic peptides are too large to cross intact skin in useful amounts, so the formula and the delivery method determine how much reaches living cells.
Peptides are short amino acid chains that act as chemical signals. On skin, they have to cross the dead outer layer before reaching a living cell.
Living skin cells below the stratum corneum, including the fibroblasts that make collagen.
Molecular size and fat solubility determine how much of a topical peptide reaches those cells.
Educational Disclaimer. This article is for informational purposes only and does not constitute medical advice. It gives no dosing or injection guidance. Talk to a licensed physician before starting any injectable peptide.
Executive summary
- The July committee vote is advisory. FDA's compounding advisory committee voted 8 to 6, with one abstention, for BPC-157, KPV, and TB-500, and FDA still has to sign off[15,16].
- BPC-157's human record covers about 30 people, across three small pilot studies with no control group[14].
- Seven of the nine peptides we weighed exceed the 500-dalton guide for skin penetration[2]. Fig. 1 plots each weight.
- Topical peptides barely register in trials. A 2026 meta-analysis of 19 randomized trials counted 17 oral studies and 2 topical ones, and the topical effect on wrinkles was non-significant[3].
- Microneedle gains depend on peptide size. In human skin pretreated with 700-micron needles, the smallest peptide gained the most and palmitoyl pentapeptide-4 showed no consistent gain[4].
How a peptide gets through skin
Your outer skin layer, the stratum corneum, is a stack of dead cells sealed with fats. A peptide in a cream has to cross it to reach anything alive.
Molecular size limits what gets through: nearly every drug and allergen known to cross intact skin weighs under about 500 daltons, the unit of molecular weight[2]. Polarity also matters. Peptides are water-loving, often charged chains, and the fats in the stratum corneum repel them[6].
Chemists add a fatty-acid tail, usually palmitic acid, to fix the polarity problem, and the tail adds weight. KTTKS, a collagen fragment, weighs 564 daltons; with the tail it weighs 802[6]. Ingredients named "palmitoyl" on a label have this tail attached.
In a 2015 penetration study, researchers applied a 10% acetyl hexapeptide-8 (Argireline) cream to human and guinea pig skin, and most of it washed off. About 0.01% reached the living epidermis, and none was detected in the dermis[7].
Molecular weight is one of the best predictors of skin penetration, and peptide product labels rarely state it.
GOA Magazine · Delivery ScienceWhat each peptide class has behind it
Most products sold as peptides for skin fit the four classes below; Gorouhi and Maibach's review supplies the fourth[9]. Much of the data in every class comes from ingredient makers, in small, short trials[9]. Read each result as ingredient evidence for the molecule in a test formula.
The most-cited signal-peptide trial dates to 2005. Ninety-three women used 3 ppm palmitoyl pentapeptide-4 on one side of the face and a placebo on the other for 12 weeks, and researchers reported significant improvement in wrinkles and fine lines on the peptide side[8].
| Class and examples | Evidence level |
|---|---|
| Signal: prompts collagen production in lab studiesPalmitoyl tripeptide-1, palmitoyl tripeptide-5, palmitoyl tetrapeptide-7, palmitoyl pentapeptide-4 (Matrixyl) | Small controlled human trials, mostly industry-linked |
| Carrier: delivers copper to tissueGHK-Cu, the copper-bound GHK tripeptide | Mostly lab and animal data; few controlled human skin trials |
| Neurotransmitter-modulating: targets the nerve signal behind expression linesAcetyl hexapeptide-8 (Argireline, formerly listed as acetyl hexapeptide-3), dipeptide diaminobutyroyl benzylamide diacetate (Syn-Ake) | Small, short trials; minimal penetration in lab testing |
| Enzyme inhibitor: slows enzymes that degrade skin proteinsFourth class, per Gorouhi and Maibach | Sparse human data |
The 2026 FDA timeline
Injected peptides fall under compounding law. For these peptides, a pharmacy's legal basis to compound is FDA's 503A bulks list[18], which also sets BPC-157's legal status in 2026. At our October 20 check, none of the peptides below appeared on it[1,20].
FDA placed 19 peptide or peptide-related substances, including BPC-157 and injectable GHK-Cu, in Category 2, its significant-safety-risk list, which ended their lawful compounding by licensed pharmacies[18,19].
HHS Secretary Robert F. Kennedy Jr. told Joe Rogan that FDA would act within weeks on roughly 14 restricted peptides[17].
FDA removed 12 peptides from Category 2 after their nominators withdrew them, effective about April 22[17]. Removal dropped the safety-risk label and authorized no compounding[18].
FDA returned non-injectable GHK-Cu to Category 1, the under-evaluation list, after a nominator clarified it meant to withdraw only the injectable route[1]. Injectable GHK-Cu sits on none of FDA's 503A lists[19]. A committee review of GHK-Cu is due before the end of February 2027[1].
The committee recommended BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax and rejected emideltide[15]. FDA staff scientists had recommended against all seven[21].
What to ask before you pay
Ask a provider the first four questions out loud, then take the answers to a physician with no stake in the sale. Use the last two on any peptide product.
| Question | Answer worth accepting |
|---|---|
| Is this peptide on FDA's 503A bulks list today? | A yes you can confirm on FDA's site the same day |
| Who compounded it, and can I see the certificate of analysis? | A named 503A pharmacy and a batch-specific certificate from an FDA-registered facility |
| What human data supports this use? | Controlled human trials for your goal. We found none for BPC-157 or injectable GHK-Cu. |
| What is the plan if I react? | A physician-supervised plan, in writing |
| Does it say "research use only"? | If yes, decline the product |
| Is it tested for use after microneedling? | Required before use on rolled skin |
What the research flags
Secretary Kennedy, a self-described "big fan" of peptides, called the unregulated supply "very, very substandard" and said buyers "have no idea" whether they are getting a legitimate product[17]. Vials sold "for research use only" carry no identity or purity standard for human use.
Over 80% of the 190-plus BPC-157 papers on PubMed list P. Sikiric or S. Seiwerth as first or senior author[11]. A 2025 review flagged open questions about long-term effects on blood-vessel growth[10]. The World Anti-Doping Agency has prohibited it since 2022[14].
Three women developed facial granulomas, firm inflammatory nodules, after microneedle treatments; two had a vitamin C serum applied during the session, and biopsies showed foreign-body reactions[12].
A 2025 meta-analysis of 23 collagen supplement trials and 1,474 people found pooled skin benefits that vanished in the high-quality and non-industry-funded trials[13].
Where a 0.3 mm roller fits
Microneedles open temporary channels through the stratum corneum. In pig skin, 150-micron needles raised Argireline's flux more than 31-fold, and permeation fell as peptide weight rose[5].
GOA's Microneedle Roller is [COUNSEL-APPROVED ROLLER DESCRIPTION]. For home use, sterilize it before each session, start once a week, keep it off the eye area and active breakouts, and apply a formula tested for use after rolling right away. Microneedling for Men covers the full protocol.
Injection skips the skin barrier entirely and falls under the FDA timeline above.
Protocol System
Apply Regenerative Face Cream to clean, dry skin. Its five peptides span two classes: palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 and palmitoyl tripeptide-5 (signal), plus acetyl hexapeptide-3 and Syn-Ake (neurotransmitter-modulating).
Apply the cream again, then pat Anti-Fatigue Undereye Serum under the eyes. It carries the same three signal peptides, formulated for the undereye area.
Roll one evening a week, following the roller steps above.
Photograph your face in the same light on day one and at week 12, then judge.
Subscribe + Save 15% on the routine [CONFIRM ON PUBLISH DAY].
Keep Reading
FAQs
Is palmitoyl tripeptide-1 the same as GHK-Cu?
Palmitoyl tripeptide-1 is the GHK sequence with a palmitic acid tail and no copper, which makes it a signal peptide. Copper-peptide research covers GHK-Cu, the copper-bound form, which belongs to the carrier class.
Do peptide creams irritate skin?
Peptides were well tolerated, with minimal adverse events, in the 2026 meta-analysis above[3]. If your skin reacts easily, patch-test new products on your jawline for a few days.
Are peptide injections safe for skin goals?
The human data is too thin to say. We found no published trial of injected GHK-Cu for skin, and NPR reported in September 2026 that efforts to move GHK-Cu longevity research into human trials have proven fruitless[22].
Is Argireline Botox in a jar?
Argireline mimics a fragment of SNAP-25, a protein in the nerve-signal complex that botulinum toxin also targets[7]. It is sold as a cosmetic ingredient, and in the 2015 penetration study described above, very little of it reached living skin.
- US Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A of the FD&C Act (updated May 14, 2026). FDA 2026. https://www.fda.gov/media/94155/download
- Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology 2000;9(3):165-169. https://pubmed.ncbi.nlm.nih.gov/10839713/
- Jfri A, et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine 2026;13:1618306. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1618306/full
- Mohammed YH, Yamada M, Lin LL, et al. Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin. PLoS One 2014;9(7):e101956. https://pmc.ncbi.nlm.nih.gov/articles/PMC4102460/
- Zhang S, Qiu Y, Gao Y. Enhanced delivery of hydrophilic peptides in vitro by transdermal microneedle pretreatment. Acta Pharmaceutica Sinica B 2014;4(1):100-104. https://pmc.ncbi.nlm.nih.gov/articles/PMC4590292/
- Mortazavi SM, Kobarfard F, Manafi A, Maibach HI, Moghimi HR. Terpene conjugation: a novel approach for topical peptide delivery. Journal of Cosmetic Science 2021;72(5). https://library.scconline.org/v072n05/56
- Kraeling MEK, Zhou W, Wang P, Ogunsola OA. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutaneous and Ocular Toxicology 2015. Reviewed in: Meet Argireline, the neurotoxinlike cosmeceutical. MDedge Dermatology. https://www.mdedge.com/dermatology/article/256393/aesthetic-dermatology/meet-argireline-neurotoxinlike-cosmeceutical/page/0/1
- Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science 2005;27(3):155-160. https://pubmed.ncbi.nlm.nih.gov/18492182/
- Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science 2009;31(5):327-345. https://pubmed.ncbi.nlm.nih.gov/?term=Gorouhi+Maibach+role+of+topical+peptides+aged+skin
- Józwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and possible medical application of the BPC 157 peptide: literature and patent review. Pharmaceuticals 2025;18(2):185. https://pmc.ncbi.nlm.nih.gov/articles/PMC11859134/
- Józwiak M, Bauer M, Kamysz W, Kleczkowska P. Reply to Sikiric et al. on BPC 157 therapy. Pharmaceuticals 2025;18(10):1451. https://www.mdpi.com/1424-8247/18/10/1451
- Soltani-Arabshahi R, Wong JW, Duffy KL, et al. Facial allergic granulomatous reaction and systemic hypersensitivity associated with microneedle therapy for skin rejuvenation. JAMA Dermatology 2014;150(1):68-72. https://pubmed.ncbi.nlm.nih.gov/24258303/
- Myung SK, Park Y. Effects of collagen supplements on skin aging: a systematic review and meta-analysis of randomized controlled trials. American Journal of Medicine 2025;138(9):1264-1277. https://pubmed.ncbi.nlm.nih.gov/40324552/
- Pharmacy Times. Heal or harm? Body Protective Compound-157 in the gray zone. Pharmacy Times 2026. https://pharmacytimes.com/view/heal-or-harm-body-protective-compound-157-in-the-gray-zone
- McDermott. Bulk-list bound? PCAC backs majority of peptides in two-day public meeting. McDermott 2026. https://www.mcdermottlaw.com/insights/bulk-list-bound-pcac-backs-majority-of-peptides-in-two-day-public-meeting/
- ABC News. FDA advisers narrowly vote to add 6 peptides to a drug compounding list. ABC News 2026. https://abcnews.com/Health/fda-advisers-narrowly-vote-add-6-peptides-drug/story?id=135064915
- Orrick. FDA announces removal of 12 peptides from Category 2 and schedules PCAC meetings. Orrick 2026. https://www.orrick.com/en/Insights/2026/04/FDA-Announces-Removal-of-12-Peptides-from-Category-2-and-Schedules-PCAC-Meetings
- Polsinelli. Tiny chains, big changes? What FDA's latest actions mean for peptide compounding. Polsinelli 2026. https://www.polsinelli.com/health-care/publications/what-fdas-latest-actions-mean-for-peptide-compounding
- Sheppard Mullin. What to watch: status update on peptide regulation. Sheppard 2026. https://www.sheppard.com/insights/blogs/what-to-watch-status-update-on-peptide-regulation
- Buchanan Ingersoll & Rooney. FDA advisory committee voted yes on six peptides. Now what? The regulatory road ahead. BIPC 2026. https://www.bipc.com/fda-voted-yes-on-six-peptides-now-what-the-regulatory-road-ahead
- AJMC. FDA panel backs 6 peptides for compounding. American Journal of Managed Care 2026. https://www.ajmc.com/view/fda-panel-backs-6-peptides-for-compounding
- NPR. The copper peptide trend has gone from creams to injections, ahead of the science. NPR via KUNC 2026. https://www.kunc.org/2026-09-07/the-copper-peptide-trend-has-gone-from-creams-to-injections-ahead-of-the-science
